Literature DB >> 17240304

Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors.

Ondrej Daum1, Petr Grossmann, Tomas Vanecek, Radek Sima, Petr Mukensnabl, Michal Michal.   

Abstract

In this study, 60 gastrointestinal stromal tumors of the stomach were analyzed to elucidate the possible relation of their morphology to the mutation status of KIT and PDGFRA genes. The patients included 27 men and 33 women with a mean age of 63.8 years (range, 12-92 years). Only 1 tumor occurred before the age of 21 years. KIT mutations were detected in 31 cases (51.7%), PDGFRA mutations in 22 cases (36.7%), and 7 cases (11.7%) were KIT and PDGFRA wild type. When the mutation status was correlated with histologic features of the tumors, epithelioid or mixed epithelioid/spindle cell pattern and mast cell infiltration were found as the most reliable signs of PDGFRA mutation. Neoplastic rhabdoid cells and multinucleated giant cells, also previously reported as features of PDGFRA-mutated gastrointestinal stromal tumors, seemed to be less specific but still helpful markers in our study. Finally, tumor-infiltrating lymphocytes and myxoid stroma do not seem to be valuable histologic signs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17240304     DOI: 10.1016/j.anndiagpath.2006.10.002

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  9 in total

1.  Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors.

Authors:  Mara Silva; Isabel Veiga; Franclim R Ribeiro; Joana Vieira; Carla Pinto; Manuela Pinheiro; Bárbara Mesquita; Catarina Santos; Marta Soares; José Dinis; Lúcio Santos; Paula Lopes; Mariana Afonso; Carlos Lopes; Manuel R Teixeira
Journal:  BMC Med       Date:  2010-05-14       Impact factor: 8.775

Review 2.  Myxoid epithelioid gastrointestinal stromal tumor harboring an unreported PDGFRA mutation: report of a case and review of the literature.

Authors:  Shogo Tajima; Akihiko Ohata; Kenji Koda; Yasuhiko Maruyama
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 3.  [Mesenchymal tumors and tumor-like lesions of the gastrointestinal tract: an overview].

Authors:  Abbas Agaimy
Journal:  Pathologe       Date:  2021-12-17       Impact factor: 1.011

4.  Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).

Authors:  Abbas Agaimy; Claudia Otto; Alexander Braun; Helene Geddert; Inga-Marie Schaefer; Florian Haller
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

5.  C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma.

Authors:  Rosario S Rivera; Hitoshi Nagatsuka; Mehmet Gunduz; Beyhan Cengiz; Esra Gunduz; Chong Huat Siar; Hidetsugu Tsujigiwa; Ryo Tamamura; Kok Ng Han; Noriyuki Nagai
Journal:  Virchows Arch       Date:  2007-12-08       Impact factor: 4.064

6.  Gastrointestinal stromal tumors: molecular mechanisms and targeted therapies.

Authors:  Erinn Downs-Kelly; Brian P Rubin
Journal:  Patholog Res Int       Date:  2011-04-14

7.  Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours.

Authors:  Dolores Di Vizio; Francesca Demichelis; Sara Simonetti; Guido Pettinato; Luigi Terracciano; Luigi Tornillo; Michael R Freeman; Luigi Insabato
Journal:  BMC Cancer       Date:  2008-05-13       Impact factor: 4.430

Review 8.  Gastrointestinal stromal tumor - an evolving concept.

Authors:  Luigi Tornillo
Journal:  Front Med (Lausanne)       Date:  2014-11-11

9.  Genetic variations in the TERT and CLPTM1L gene region and gastrointestinal stromal tumors risk.

Authors:  Rui Zhang; Jian Zhao; Jian Xu; Fang Liu; Yongqing Xu; Xianmin Bu; Chaoliu Dai; Chun Song
Journal:  Oncotarget       Date:  2015-10-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.